Evaluation of the use of microcrystalline chitosan and collagen membranes as carriers for the platelet derived growth factor (PDGF-BB) in the presence of amoxicillin

Authors

  • Kazimiera H. Bodek Department of Applied Pharmacy, Faculty of Pharmacy, Medical University of Lodz, Poland Author
  • Marta Michalska Department of Pharmaceutical Biochemistry, Faculty of Pharmacy, Medical University of Lodz, Poland Author
  • Andrzej Bodek Institute of Biopolymers and Chemical Fibres, Łódź, Poland Author
  • Marcin Kozakiewicz Department of Maxillofacial Surgery, Medical University of Lodz, Poland Author

DOI:

https://doi.org/10.12923/j.2084-980X/26.2/a.13

Keywords:

microcrystalline chitosan (MCCh), collagen (Coll), platelet derived growth factor (PDGF-BB), amoxicillin (Am), kinetics of PDGF-BB and Am release

Abstract

The aim of the present study was to evaluate the in vitro release of platelet-derived growth factor (PDGF-BB) from homogeneous microcrystalline chitosan (MCCh), collagen (Coll) and composite microcrystalline chitosan - collagen (MCCh-Coll) membranes in the presence or absence of amoxicillin (Am) and to select the most useful membrane for its practical application. The films were characterized by means of FTIR spectroscopy, swelling studies and SEM images. The kinetics of PDGF-BB release was evaluated by means of the ELISA immunoassay test. Amoxicillin concentration was determined spectrophotometrically at 273 nm. The process of the PDGF-BB growth factor and amoxicillin release from studied membranes was of two-phase nature. The first phase (during the 8 h) was characterized by rapid release whereas in the second phase (up to 10 days) the release was much slower. MCCh-Coll (M4) composite membrane appeared to be the most useful membrane because of the fast release of PDGF-BB as a significant angiogenic growth factor for tissue regeneration and the slow as well as gradual release of the antibiotic (amoxicillin), which carries protective role during regeneration process.

References

1. Ahuja A., Ali J., Rahman S.: Biodegradable periodontal intrapocket device containing metronidazole and amoxicillin: formulation and characterisation. Pharmazie, 61, 25, 2006.

2. AlBuhairan B., Hind D., Hutchinson A.: Antibiotic prophylaxis for wound infections in total joint arthroplasty: a systematic review. J. Bone Joint. Surgery Br., 90-B, 915, 2008.

3. Bodek K.H.: Evaluation of properties microcrystalline chitosan as a drug carrier. Part I. In vitro release of diclofenac from microcrystalline chitosan hydrogel. Acta Polon. Pharm. – Drug Research, 57, 431, 2000.

4. Candy T., Sharma C. P.: Chitosan – as a biomaterial. Art. Cells. Art. Organs, 18,1-24, 1999.

5. Heldin C.H., Westermark B.: Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev., 79, 1283, 1999.

6. Holland T.A., Mikos A.G.: Biodegradable polymeric scaffolds. Improvements in bone tissue engineering through controlled drug delivery. Adv. Biochem.. Eng. Biotechnol., 102, 161, 2006.

7. Kaigler D. et al.: Platelet-derived growth factor applications in periodontal and peri-implant bone regeneration. Expert. Opin. Biol. Ther., 11, 375, 2011.

8. Kubis A.A., Musiał W., Szcześniak M.: Influence of some polysorbates on hydrocortisone release from hydrophilic gels considered as two-compartment models. Pharmazie, 57, 479, 2002.

9. Lee S-H., Shin H.: Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering. Adv. Drug. Deliv. Rev., 59, 339, 2007.

10. Michalska M. et al.: Evaluation of the use of fibrin and microcrystalline chitosan membranes as carriers for transforming growth factor beta-1 (TGF-b1). J. Appl. Polym. Sci., 127, 3506, 2013.

11. Mistry A.S., Mikos A.G.: Tissue engineering strategies for bone regeneration. Adv. Biochem. Eng. Biotechnol., 94, 1, 2005.

12. Park Y.J., Lee Y., Park S.N., Sheen S.Y., Chung C.P., Lee S.J.: Platelet derived growth factor releasing chitosan sponge for periodontal bone regeneration. Biomaterials, 21, 153, 2000.

13. Sionkowska A. et al.: Molecular interactions in collagen and chitosan blends. Biomaterials, 25, 795, 2004.

14. Stephan E.B. et al.: Platelet-derived growth factor enhancement of mineral-collagen bone substitute. J. Periodontol.,71, 1887, 2000.

15. Struszczyk H.: Microcrystalline chitosan. I. Preparation and properties of microcrystalline chitosan. J. Appl. Polym. Sci., 33, 177, 1987.

16. Tan S.C. et al.: The degree of deacetylation of chitosan: advocating the first derivative UV-spectrophotometry method of determination. Talanta, 45, 713, 1998.

Downloads

Published

2013-05-01

Issue

Vol. 26 No. 2 (2013): Current Issues of Pharmacy and Medical Sciences

Section

Artykuły

License

Copyright (c) 2013 Authors

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 Unported License.

How to Cite

Bodek, K. H., Michalska, M., Bodek, A., & Kozakiewicz, M. (2013). Evaluation of the use of microcrystalline chitosan and collagen membranes as carriers for the platelet derived growth factor (PDGF-BB) in the presence of amoxicillin. Current Issues in Pharmacy and Medical Sciences, 26(2), 176-182. https://doi.org/10.12923/j.2084-980X/26.2/a.13